glp-1 for addiction treatment IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target Not just obesity: GLP-1 receptor
Description
Meals become fuel, not fixation
From there, higher order neurons follow this labeling over the brainstem to the primary gustatory cortex which seems to be located in the insula [54,55]
With proper monitoring, you can identify the exact dose where your body begins responding, spot side effects before they become problematic, and adjust your protocol based on evidence rather than intuition
9,10 These actions change eating behaviour: the anticipatory food reward for looking forward to eating certain (delicious) foods decreases, while consummatory food reward (the pleasure offered by eating) increases
Other Possible Side Effects Most common side effects are mild and improve over time, especially when you have a team of experts like the dietitians and nutritionists at Nutrisense to help support you
Across the SURPASS program, tirzepatide reduced SBP vs
